Allarity Therapeutics Files 8-K

Ticker: ALLR · Form: 8-K · Filed: May 13, 2025 · CIK: 1860657

Sentiment: neutral

Topics: 8-k, sec-filing, pharmaceutical

Related Tickers: ALLR

TL;DR

ALLR filed an 8-K, check for updates.

AI Summary

Allarity Therapeutics, Inc. filed an 8-K on May 13, 2025, reporting other events and financial statements. The company, incorporated in Delaware with its principal executive offices in Tarpon Springs, FL, is in the pharmaceutical preparations industry.

Why It Matters

This filing indicates a routine update or disclosure from Allarity Therapeutics, Inc. to the SEC, which may contain important information for investors regarding company events or financial status.

Risk Assessment

Risk Level: low — This is a standard 8-K filing for reporting events and financial statements, not indicating any immediate or significant negative developments.

Key Numbers

Key Players & Entities

FAQ

What specific 'Other Events' are being reported in this 8-K filing?

The filing indicates 'Other Events' as an item information, but the specific details of these events are not provided in the provided text excerpt.

What is the primary business of Allarity Therapeutics, Inc. according to the SIC code?

The Standard Industrial Classification (SIC) code provided is 2834, which corresponds to 'Pharmaceutical Preparations'.

When was the earliest event reported in this Form 8-K?

The date of the earliest event reported is May 12, 2025.

Where are Allarity Therapeutics, Inc.'s principal executive offices located?

The principal executive offices are located at 123 E Tarpon Ave, Tarpon Springs, FL 34689.

What is the company's telephone number?

The registrant's telephone number, including area code, is (401) 426-4664.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 13, 2025 regarding Allarity Therapeutics, Inc. (ALLR).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing